ID

34157

Description

A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01363986

Link

https://clinicaltrials.gov/show/NCT01363986

Keywords

  1. 1/14/19 1/14/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 14, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01363986

Eligibility Breast Cancer NCT01363986

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/=18 years of age
Description

ID.1

Data type

boolean

diagnosis of breast carcinoma with her-2 overexpression
Description

ID.2

Data type

boolean

at least one measurable brain metastasis
Description

ID.3

Data type

boolean

patients for whom, according to investigator assessment, whole brain radiotherapy is the best therapeutic option
Description

ID.4

Data type

boolean

performance status (who) </=2
Description

ID.5

Data type

boolean

life expectancy >/=3 months
Description

ID.6

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of neoplastic meningitis
Description

ID.7

Data type

boolean

any prior radiotherapy to the brain
Description

ID.8

Data type

boolean

patients for whom, according to investigator assessment, stereotactic radiotherapy is the best therapeutic option
Description

ID.9

Data type

boolean

previous neoplasms, other than breast carcinoma, within 5 years since enrolment
Description

ID.10

Data type

boolean

Similar models

Eligibility Breast Cancer NCT01363986

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
diagnosis of breast carcinoma with her-2 overexpression
boolean
ID.3
Item
at least one measurable brain metastasis
boolean
ID.4
Item
patients for whom, according to investigator assessment, whole brain radiotherapy is the best therapeutic option
boolean
ID.5
Item
performance status (who) </=2
boolean
ID.6
Item
life expectancy >/=3 months
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
presence of neoplastic meningitis
boolean
ID.8
Item
any prior radiotherapy to the brain
boolean
ID.9
Item
patients for whom, according to investigator assessment, stereotactic radiotherapy is the best therapeutic option
boolean
ID.10
Item
previous neoplasms, other than breast carcinoma, within 5 years since enrolment
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial